P1116: SAFETY, PHARMACOKINETIC (PK), PHARMACODYNAMIC (PD) AND ACTIVITY OF THE HIGHLY SELECTIVE PHOSPHOINOSITIDE 3-KINASE INHIBITOR DELTA (PI3KΔ) INHIBITOR IOA-244 IN PATIENTS WITH FOLLICULAR LYMPHOMA (FL). (23rd June 2022) - Carlostella, C.; Lahn, M.; Hammett, T.; van der Veen, L.; Johnson, Z.; Pickering, C.; Santoro, A.